Baidu
map

肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2020 ESTRO/EORTC共识建议：寡转移性疾病的特征和分类

2020-01-02 欧洲放射肿瘤学学会 Lancet Oncol. 2020 Jan;21(1):e18-e28.

寡转移性疾病

2020年1月，欧洲放射肿瘤学学会(ESTRO)联合欧洲癌症治疗研究组织(EORTC)共同发布了寡转移性疾病的特征和分类建议，寡转移性疾病被认为是局部和全身性转移疾病的中间状态，本文主要介绍了寡转移性疾病的特征和分类。

中文标题：

2020 ESTRO/EORTC共识建议：寡转移性疾病的特征和分类

英文标题：

Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation.

发布机构：

欧洲放射肿瘤学学会

发布日期：

2020-01-02

简要介绍：

2020年1月，欧洲放射肿瘤学学会(ESTRO)联合欧洲癌症治疗研究组织(EORTC)共同发布了寡转移性疾病的特征和分类建议，寡转移性疾病被认为是局部和全身性转移疾病的中间状态，本文主要介绍了寡转移性疾病的特征和分类。

 

拓展指南：与转移相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2020 ESTRO/EORTC共识建议：寡转移性疾病的特征和分类)] GetToolGuiderByIdResponse(projectId=1, id=1faf81c001850e5f, title=2020 ESTRO/EORTC共识建议：寡转移性疾病的特征和分类, enTitle=Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation., guiderFrom=Lancet Oncol. 2020 Jan;21(1):e18-e28., authorId=null, author=, summary=2020年1月，欧洲放射肿瘤学学会(ESTRO)联合欧洲癌症治疗研究组织(EORTC)共同发布了寡转移性疾病的特征和分类建议，寡转移性疾病被认为是局部和全身性转移疾病的中间状态，本文主要介绍了寡转移性疾病的特征和分类。 , cover=, journalId=null, articlesId=null, associationId=1624, associationName=欧洲放射肿瘤学学会, associationIntro=, copyright=0, guiderPublishedTime=Thu Jan 02 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<P>2020年1月，欧洲放射肿瘤学学会(ESTRO)联合欧洲癌症治疗研究组织(EORTC)共同发布了寡转移性疾病的特征和分类建议，寡转移性疾病被认为是局部和全身性转移疾病的中间状态，本文主要介绍了寡转移性疾病的特征和分类。 </P> <P> </P>拓展指南：<strong>与<font color=red>转移</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=6403f1c0018a43a7" title="复发/转移性乳腺癌标志物临床应用专家共识（2019年版）" target=_blank>复发/转移性乳腺癌标志物临床应用专家共识（2019年版）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=b11861c001839356" title="2019 多学科共识文件：转移性激素敏感和转移性去势抵抗性前列腺癌患者的监测" target=_blank>2019 多学科共识文件：转移性激素敏感和转移性去势抵抗性前列腺癌患者的监测</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=1ef331c0018353a5" title="转移性前列腺癌化疗中国专家共识（2019版）" target=_blank>转移性前列腺癌化疗中国专家共识（2019版）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=023591c001e96385" title="ASCO临床实践指南：非转移成人癌症幸存者骨质疏松症的管理 2019" target=_blank>ASCO临床实践指南：非转移成人癌症幸存者骨质疏松症的管理 2019</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=750771c001e887bd" title="结直肠癌腹膜转移预防和治疗腹腔用药中国专家共识（V 2019）" target=_blank>结直肠癌腹膜转移预防和治疗腹腔用药中国专家共识（V 2019）</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E8%BD%AC%E7%A7%BB" target=_blank>有关转移更多指南</a></ul>, tagList=[TagDto(tagId=98886, tagName=寡转移性疾病)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6584, appHits=114, showAppHits=0, pcHits=3132, showPcHits=5493, likes=44, shares=6, comments=2, approvalStatus=1, publishedTime=Fri Jan 17 23:01:43 CST 2020, publishedTimeString=2020-01-02, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Jan 17 23:01:43 CST 2020, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 02:11:49 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2020 ESTRO/EORTC共识建议：寡转移性疾病的特征和分类)])
2020 ESTRO/EORTC共识建议：寡转移性疾病的特征和分类
下载请点击：
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1013677, encodeId=412610136e774, content=寡转移, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLibWZaJnsQQpPMmtvCWwFKRr7lrLE7smStbccAmh0afpDnpASvnsrPeo0saeenF61ED3pzq7Pqfew/132, createdBy=d4355313033, createdName=mission, createdTime=Thu Sep 02 09:31:51 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895350, encodeId=4cec89535080, content=<a href='/topic/show?id=b0484660060' target=_blank style='color:#2F92EE;'>#寡转移#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46600, encryptionId=b0484660060, topicName=寡转移)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Thu Oct 29 10:19:13 CST 2020, time=2020-10-29, status=1, ipAttribution=)]
    2021-09-02 mission

    寡转移

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1013677, encodeId=412610136e774, content=寡转移, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLibWZaJnsQQpPMmtvCWwFKRr7lrLE7smStbccAmh0afpDnpASvnsrPeo0saeenF61ED3pzq7Pqfew/132, createdBy=d4355313033, createdName=mission, createdTime=Thu Sep 02 09:31:51 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895350, encodeId=4cec89535080, content=<a href='/topic/show?id=b0484660060' target=_blank style='color:#2F92EE;'>#寡转移#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46600, encryptionId=b0484660060, topicName=寡转移)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Thu Oct 29 10:19:13 CST 2020, time=2020-10-29, status=1, ipAttribution=)]
    2020-10-29 lovetcm

    #寡转移#

    0

Baidu
map
Baidu
map
Baidu
map